Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Lotilaner by Tarsus Pharmaceuticals for Meibomian Blepharitis: Likelihood of Approval
Lotilaner is under clinical development by Tarsus Pharmaceuticals and currently in Phase II for Meibomian Blepharitis. According to GlobalData, Phase...